The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.

@article{Kesselheim2016TheHC,
  title={The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.},
  author={A. Kesselheim and J. Avorn and A. Sarpatwari},
  journal={JAMA},
  year={2016},
  volume={316 8},
  pages={
          858-71
        }
}
  • A. Kesselheim, J. Avorn, A. Sarpatwari
  • Published 2016
  • Medicine
  • JAMA
  • IMPORTANCE The increasing cost of prescription drugs in the United States has become a source of concern for patients, prescribers, payers, and policy makers. [...] Key MethodEVIDENCE We reviewed the peer-reviewed medical and health policy literature from January 2005 to July 2016 for articles addressing the sources of drug prices in the United States, the justifications and consequences of high prices, and possible solutions. Expand Abstract
    286 Citations

    Paper Mentions

    Interventional Clinical Trial
    Pheochromocytoma is a rare, catecholamine (ex. adrenaline) secreting tumor that requires preoperative alpha blockade to minimize intraoperative hemodynamic instability, thereby… Expand
    ConditionsParaganglioma, Pheochromocytoma
    InterventionDrug
    Variation in Prescription Drug Prices by Retail Pharmacy Type
    • 4
    Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
    • 43
    • Highly Influenced
    • PDF
    Myths and Realities About Why Prescription Drug Prices in the United States Are So High
    National trends in prescription drug expenditures and projections for 2017.
    • G. Schumock, E. Li, +5 authors L. Vermeulen
    • Medicine
    • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
    • 2017
    • 41
    • PDF
    Trajectories of Injectable Cancer Drug Costs After Launch in the United States.
    • 28
    The high price of anticancer drugs: origins, implications, barriers, solutions
    • 127
    • PDF
    Trends in Pricing and Generic Competition Within the Oral Antibiotic Drug Market in the United States
    • 12
    • PDF

    References

    SHOWING 1-10 OF 156 REFERENCES
    US pharmaceutical innovation in an international context.
    • 26
    'Government Patent Use': A Legal Approach To Reducing Drug Spending.
    • 20
    • PDF
    High-cost generic drugs--implications for patients and policymakers.
    • 34